LeMaitre Vascular Goodwill and Intangible Assets 2010-2025 | LMAT
LeMaitre Vascular Annual Goodwill and Intangible Assets (Millions of US $) |
|
---|---|
2024 | $102 |
2023 | $108 |
2022 | $112 |
2021 | $119 |
2020 | $125 |
2019 | $65 |
2018 | $44 |
2017 | $32 |
2016 | $33 |
2015 | $24 |
2014 | $24 |
2013 | $21 |
2012 | $19 |
2011 | $15 |
2010 | $16 |
2009 | $14 |
LeMaitre Vascular Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
---|---|
2025-03-31 | $100 |
2024-12-31 | $102 |
2024-09-30 | $103 |
2024-06-30 | $105 |
2024-03-31 | $106 |
2023-12-31 | $108 |
2023-09-30 | $109 |
2023-06-30 | $110 |
2023-03-31 | $111 |
2022-12-31 | $112 |
2022-09-30 | $114 |
2022-06-30 | $116 |
2022-03-31 | $117 |
2021-12-31 | $119 |
2021-09-30 | $120 |
2021-06-30 | $122 |
2021-03-31 | $123 |
2020-12-31 | $125 |
2020-09-30 | $126 |
2020-06-30 | $129 |
2020-03-31 | $64 |
2019-12-31 | $65 |
2019-09-30 | $49 |
2019-06-30 | $42 |
2019-03-31 | $43 |
2018-12-31 | $44 |
2018-09-30 | $43 |
2018-06-30 | $31 |
2018-03-31 | $32 |
2017-12-31 | $32 |
2017-09-30 | $33 |
2017-06-30 | $33 |
2017-03-31 | $33 |
2016-12-31 | $33 |
2016-09-30 | $24 |
2016-06-30 | $24 |
2016-03-31 | $25 |
2015-12-31 | $24 |
2015-09-30 | $24 |
2015-06-30 | $25 |
2015-03-31 | $24 |
2014-12-31 | $24 |
2014-09-30 | $25 |
2014-06-30 | $20 |
2014-03-31 | $21 |
2013-12-31 | $21 |
2013-09-30 | $21 |
2013-06-30 | $19 |
2013-03-31 | $19 |
2012-12-31 | $19 |
2012-09-30 | $14 |
2012-06-30 | $14 |
2012-03-31 | $15 |
2011-12-31 | $15 |
2011-09-30 | $15 |
2011-06-30 | $15 |
2011-03-31 | $15 |
2010-12-31 | $16 |
2010-09-30 | $14 |
2010-06-30 | $14 |
2010-03-31 | $14 |
2009-12-31 | $14 |
2009-09-30 | $15 |
2009-06-30 | $15 |
2009-03-31 | $15 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $1.907B | $0.220B |
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
Boston Scientific (BSX) | United States | $154.336B | 38.64 |
Stryker (SYK) | United States | $150.874B | 31.55 |
EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
Medtronic (MDT) | Ireland | $113.364B | 16.07 |
Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
ResMed (RMD) | United States | $37.677B | 28.30 |
GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
Agilent Technologies (A) | United States | $34.480B | 22.48 |
Terumo (TRUMY) | Japan | $25.244B | 32.79 |
Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
Insulet (PODD) | United States | $21.186B | 83.16 |
Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
Baxter (BAX) | United States | $15.914B | 11.88 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
Demant (WILYY) | Denmark | $8.971B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
Haemonetics (HAE) | United States | $3.693B | 16.82 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.456B | 28.72 |
ICU Medical (ICUI) | United States | $3.333B | 24.58 |
QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
AtriCure (ATRC) | United States | $1.572B | 0.00 |
Acuren (TIC) | United States | $1.378B | 0.00 |
AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
Neogen (NEOG) | United States | $1.157B | 14.81 |
Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
InMode (INMD) | Israel | $0.958B | 9.66 |
Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
Owens & Minor (OMI) | United States | $0.712B | 5.90 |
CeriBell (CBLL) | United States | $0.684B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
Evolus (EOLS) | United States | $0.598B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
Valneva SE (VALN) | France | $0.494B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
Surmodics (SRDX) | United States | $0.429B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
Quanterix (QTRX) | United States | $0.349B | 0.00 |
SNDL (SNDL) | Canada | $0.334B | 0.00 |
Cerus (CERS) | United States | $0.294B | 0.00 |
ZimVie (ZIMV) | United States | $0.285B | 12.98 |
Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
Brainsway (BWAY) | Israel | $0.250B | 66.20 |
Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
Biote (BTMD) | United States | $0.231B | 6.49 |
OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
Organigram Global (OGI) | Canada | $0.192B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
High Tide (HITI) | Canada | $0.188B | 0.00 |
Omeros (OMER) | United States | $0.188B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
Exagen (XGN) | United States | $0.150B | 0.00 |
Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
Jin Medical (ZJYL) | China | $0.100B | 0.00 |
Fonar (FONR) | United States | $0.097B | 12.48 |
MacroGenics (MGNX) | United States | $0.092B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
Veru (VERU) | United States | $0.089B | 0.00 |
Apyx Medical (APYX) | United States | $0.087B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
Zynex (ZYXI) | United States | $0.073B | 0.00 |
InterCure (INCR) | Israel | $0.071B | 0.00 |
Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
Agape ATP (ATPC) | $0.068B | 0.00 | |
Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
ImmuCell (ICCC) | United States | $0.058B | 0.00 |
Nephros (NEPH) | United States | $0.043B | 57.57 |
Modular Medical (MODD) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.86 |
Safety Shot (SHOT) | United States | $0.030B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
Senestech (SNES) | United States | $0.012B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |